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Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Neonatal
Unit in Colombia
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Martha Isabel Garzón Aguilar,b Leslie Martinez de la Barrera,b Esther Rocio Barrero Barreto,b Ricaurte Alejandro Marquez-Ortiz,a
Maria Victoria Moncada Guayazán,a Natasha Vanegas Gómeza,c
Bacterial Molecular Genetics Laboratory, Universidad El Bosque, Bogotá, Colombiaa; Hospital El Tunal ESE, Bogotá, Colombiab; The ithree Institute, Faculty of Science,
University of Technology, Sydney, Australiac
Six multiresistant, NDM-1-producingKlebsiella pneumoniae strains were recovered from an outbreak that affected six neonatal
patients in a Colombian hospital. Molecular analysis showed that all of the isolates harbored the blaNDM-1, qnrA, and intI1 genes
and were clonally related. Multilocus sequence typing showed that the isolates belonged to a new sequence type (ST1043) that
was different from the sequence types that had previously been reported. This is the first report of NDM-1-producing isolates in
South America.
The emergence of carbapenem-resistant Gram-negative bacte-ria is a worldwide clinical problem that is associated princi-
pally with the production of carbapenemases (1). New Delhi me-
tallo--lactamase 1 (NDM-1) is a carbapenemase that confers
resistance to all -lactam antibiotics, except aztreonam (2).
NDM-1 was first identified in Klebsiella pneumoniae and Esche-
richia coli recovered from a Swedish patient who was transferred
from India and Pakistan in 2008 (2, 3). However, NDM-1-pro-
ducing Enterobacteriaceae and Acinetobacter spp. have been re-
ported in Europe, Asia, Oceania, North America (4), and recently
Central America (5). Here we report a nosocomial outbreak of
NDM-1-producing K. pneumoniae in six patients who were ad-
mitted to the neonatal unit of a general hospital in Bogotá, Co-
lombia. This is the first report of NDM-1-producing K. pneu-
moniae isolation in South America.
Table 1 shows the demographic and clinical characteristics of
the six patients who were involved in the outbreak of NDM-1-
producing K. pneumoniae. In August 2011, a preterm neonate
who was 3 weeks of age developed symptoms of late neonatal
sepsis. A carbapenem-resistant K. pneumoniae isolate was recov-
ered from the patient’s blood. The patient was treated with mero-
penem and rifampin and had an adequate clinical response and
negative blood cultures on day 4 of treatment. The patient had a
history of necrotizing enterocolitis IIB that required a total colec-
tomy and ileostomy. There is no documented clinical history of
the mother traveling outside the country, and there are no docu-
mented contacts of her or her daughter with individuals or health
care workers from countries that have previously reported NDM-
1-producing bacteria (case 1).
In December 2011, three new cases were identified. One case
was identified in a preterm newborn with enterocolitis IIB who
was initially treated with piperacillin-tazobactam. Subsequently, a
K. pneumoniae isolate was recovered from the patient’s blood and
the patient was treated with imipenem and ciprofloxacin because
the patient’s creatinine clearance was less than 25 mg/dl. The pa-
tient had an adequate clinical response and was discharged at the
end of treatment (case 2). The next case occurred in a patient with
sequela of hypoxic-ischemic encephalopathy. An isolate of K.
pneumoniaewas isolated from the patient’s blood. The patient was
treated with imipenem and ciprofloxacin and had an adequate
clinical response. This patient was in the neonatal unit at the same
time as the first patient and had previously been treated with pipera-
cillin-tazobactam and gentamicin on two occasions for aspiration
pneumonia. Additionally, carbapenem-resistant K. pneumoniae and
E. coli isolates that didnothave clinical repercussionshadbeen recov-
ered from the patient’s urine the previousmonth (case 3). The last of
the December 2011 cases was that of an extreme preterm neonate
with severe perinatal asphyxia with myocardial and renal involve-
ment, who on day 10 of hospitalization developed sepsis. K. pneu-
moniaewas isolated from the patient’s blood, catheter tip, and feces.
On day 3 of treatment with imipenem and ciprofloxacin, the patient
improved.However, the patient later developed a superior vena cava
thrombosis and died (case 4).
In January 2012, there were two new cases of K. pneumoniae in-
fection. One case was in a term infant with respiratory distress syn-
drome frompneumonia inutero. Thispatient started todeteriorate at
36 h of life and exhibited increased respiratory distress, right apical
opacity, spontaneouspneumothorax, leukopenia, and thrombocyto-
penia. K. pneumoniae was recovered from the patient’s blood. The
patientwas treatedwith imipenem(25-mg/kgdoses) and ciprofloxa-
cin (15 mg/kg). On day 3 of treatment, the blood cultures were neg-
ative for K. pneumoniae and the patient had a favorable clinical out-
come (case 5). The last casewas that of a very preterm infantwhowas
born early because of maternal chorioamnionitis. On day 13 of hos-
pitalization, the infant exhibited fulminant enterocolitis that evolved
very rapidly and the patient died. K. pneumoniae was isolated from
the patient’s blood and peritoneal fluid (case 6).
The isolates were identified and antimicrobial susceptibility was
determined with the automated MicroScan WalkAway plus system
(Dade Behring). TheMICs of meropenem, cefotaxime, ceftazidime,
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piperacillin-tazobactam, amikacin, gentamicin, ciprofloxacin, and
tetracycline were confirmed by the agar dilution method. TheMICs
of imipenem,ertapenem,andaztreonamwereconfirmedby theEtest
method (6). All isolates were confirmed as K. pneumoniae by ampli-
fication of the khe gene (7). Production of carbapenemases was de-
terminedwith amodifiedHodge test (6).Molecular characterization
of the blood isolates obtained included detection of the blaCTX-M,
blaTEM, blaSHV, blaOXA-48, blaGES, blaVIM, blaKPC, blaNDM, qnrA, qnrB,
qnrS, aac(6=)-Ib-cr, sul1, and intl1 genes and the genes coding for six
plasmid AmpC enzymes (ACC, FOX, MOX, EBC, DHA, and CIT)
(8, 9). TheNDMtypes of the isolateswere determined by sequencing
of the amplification product. The genetic relatedness of the isolates
was determined by pulsed-field gel electrophoresis (PFGE) andmul-
tilocus sequence typing (MLST) (10).
All six isolateswere resistant to all-lactams except aztreonam.
Additionally, the isolates were resistant to gentamicin, amikacin,
and trimethoprim-sulfamethoxazole but were susceptible to cip-
rofloxacin, tetracycline (6), tigecycline, and colistin (breakpoints
available at http://www.eucast.org/clinical_breakpoints/, version
2.0) (Table 1). The blaSHV, blaNDM-1, qnrA, and intl1 genes were
detected in all of the isolates. The remaining resistance genes that
were evaluatedwere not detected. PFGE analysis demonstrated a sin-
gle pulsotype, which suggests that the six isolates were clonally re-
lated. The alleles found for the gapA, infB,mdh, pgi, phoE, rpoB, and
tonB genes used for MLST were 2, 38, 2, 20, 7, 4, and 89, respec-
tively. This allelic combination corresponds to ST1043 (http://www
.pasteur.fr/mlst). To date, there are no reports of NDM-positive or
-negative isolates that belong to this sequence type (ST). The plas-
mid profile analysis of the clinical isolates showed the presence of
two plasmids of 23 and 6 kbp (11). Transconjugants were
obtained from the clinical isolates at 30 and 37°Cwith E. coli strain
CAG12177 as the recipient and selected with tetracycline and cef-
tazidime (12–14). The transconjugants were resistant to all -lac-
tams (except aztreonam) but susceptible to ciprofloxacin (MIC,
0.125 g/ml). In the NDM-positive E. coli transconjugants, only
the23-kbp plasmidwas detected and the qnrA, blaSHV, and intI1
genes were not found. Replicon typing classified this plasmid
within the IncA/C incompatibility group (15).
The genetic environment of blaNDM-1was determinedwith previ-




were designed for bleMBL, trpF, tat, groES, and groEL gene ampli-
fication. Sequencing of the PCR product revealed the presence of
the same genetic elements surrounding the blaNDM-1 gene found
in severalAcinetobacter spp. (17) andE. coli isolate 102337 (Fig. 1).
To break the chain of transmission of this organism, the staff of
the unit (including the cleaning crew) received information re-
garding the outbreak and the importance of hand hygiene. Also,
strict contact isolation precautions were implemented for the af-
fected patients. All patients whowere infectedwithK. pneumoniae
were clustered, and additional supervised disinfection sessions
were performed with sodium dichloroisocyanurate (1,000 ppm).
FIG 1 Comparative map of the genetic elements surrounding the blaNDM-1 gene found in the 16Kpn1 isolate and Acinetobacter pittii strain ABCA95 plasmid
pABCA95, Acinetobacter lwoffii strain WJ10621 plasmid pNDM-BJ01, Acinetobacter haemolyticus strain ABC7926 plasmid pABC7926, A. baumannii strain
161/07,A. baumannii strain JH,E. coli strainN10-2337 plasmid pNDM102337,E. coli strainDVR22,Providencia stuartii plasmid pMR0211,K. pneumoniae strain
Kp7 plasmid pNDM-KN, and K. pneumoniae plasmid pTR3 (GenBank accession numbers JQ739157.1, JQ001791.1, JQ080305.1, HQ857107.1, JN872329.1,
JF714412.1, JF922606.1, JN687470.1, JN157804.1, and JQ349086.2, respectively).
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Furthermore, the entry of new patients was restricted. Thesemea-
sures controlled the spread of the identified clone. Epidemiologi-
cal surveillance was intensified, and no new cases of carbapenem-
resistant K. pneumoniae were found in the neonatal unit during
the 3 months following the last isolation.
This is the first report of an outbreak of NDM-1-producing K.
pneumoniae in Colombia and South America. Additionally, it is
the first report of an outbreak in a neonatal unit of isolates that
produceNDM-1 and that had a clinical response to imipenemand
ciprofloxacin treatment. The patients were hospitalized in the
neonatal unit from birth, and contact with people from countries
that have reported the presence of NDM-1-producing bacteria
was not documented. It is therefore likely that these isolates rep-
resent a novel ST and that autochthonous clones are locally ac-
quiring plasmids carrying the gene for NDM-1, as has been re-
ported in Europe (18). This hypothesis should be investigated
further, including the possibility of horizontal transmission of
plasmids from other bacteria that have been reported as NDM-1
carriers, such as Acinetobacter baumannii and E. coli (16, 19–21).
The clonality of the isolates suggested that the bacteria were
transmitted between patients who were concurrently hospitalized
in the same room. This route was also strongly implied by the fact
that K. pneumoniae was not recovered from samples taken from
hospital surfaces, eliminating the environment as a source of in-
fection. In hospitalized adult patients, carbapenem-resistant K.
pneumoniae isolates were identified; however, these isolates were
resistant to aztreonam and molecular characterization indicated
that they were KPC-3 positive, NDM negative, and genetically
unrelated to NDM-1-producing K. pneumoniae, as has been pre-
viously reported by our group (22).
Our findings are consistent with other reports that have dem-
onstrated the ease of nosocomial spread of resistant members of
the family Enterobacteriaceae that cause infections and that man-
ifest limited treatment options and high mortality rates. For this
reason, it is important to reinforce infection control measures, to
avoid cross-dissemination of multidrug-resistant microorgan-
isms, to strengthen epidemiological surveillance systems that pro-
vide feedback to those involved in the management of patients,
and to implement appropriate intervention measures.
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